| 000 | 01342 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517184554.0 | ||
| 264 | 0 | _c20190522 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a2168-6084 | ||
| 024 | 7 |
_a10.1001/jamadermatol.2017.4374 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMicieli, Robert | |
| 245 | 0 | 0 |
_aTreatment for Livedoid Vasculopathy: A Systematic Review. _h[electronic resource] |
| 260 |
_bJAMA dermatology _c02 2018 |
||
| 300 |
_a193-202 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Systematic Review | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 |
_aAnticoagulants _xpharmacology |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperbaric Oxygenation _xmethods |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadministration & dosage |
| 650 | 0 | 4 |
_aLivedo Reticularis _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPUVA Therapy _xmethods |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSkin Diseases, Vascular _xdiagnosis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAlavi, Afsaneh | |
| 773 | 0 |
_tJAMA dermatology _gvol. 154 _gno. 2 _gp. 193-202 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamadermatol.2017.4374 _zAvailable from publisher's website |
| 999 |
_c27791398 _d27791398 |
||